logo_artidis.png
MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment
October 03, 2022 09:05 ET | ARTIDIS AG
HOUSTON and BASEL, Switzerland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- ARTIDIS AG, the developer of the first nanomechanical technology platform for tissue analytics, and The University of Texas MD...
FBI LOGO TM.png
Pancreatic Cancer Treatment Market Size [2022-2029] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecast
September 28, 2022 07:22 ET | Fortune Business Insights
Pune, India, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The global pancreatic cancer treatment market size is expected to rise substantially owing to increasing consumption of cigarettes and rising...
sq_logo_gradient.png
Global Pancreatic Cancer Treatment Market to Generate Revenue of $3.78 Billion by 2028 | AI is Slowly Budding to Improve Diagnosis Accuracy of Pancreatic Cancer
September 22, 2022 09:36 ET | SkyQuest Technology Consulting Pvt. Ltd.
Westford,USA, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Pancreatic cancer is 12th the deadliest forms of cancer, with a 5-year survival rate of just 15%. As a result, there is a strong growth momentum in...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Announces Top-Line Data From ELAINE 1 Phase 2 Study of Lasofoxifene Versus Fulvestrant Is Accepted for a Late-Breaking Oral Presentation at ESMO Congress 2022
August 25, 2022 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
sq_logo_gradient.png
Global Cancer Diagnostics Market: North American Companies Generated 64% of Global Revenue in 2021
July 28, 2022 08:54 ET | SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, July 28, 2022 (GLOBE NEWSWIRE) -- Cancer diagnostics market is growing rapidly with high potential for growth. The disease burden from cancer is increasing and there is an increasing...
researchdrivelogo.jpg
Global Medical Tourism Market Envisioned to Generate a Revenue of $149.34 Billion and Rise at a CAGR of 12.4% over the Analysis Timeframe from 2019 to 2026
July 11, 2022 09:15 ET | Research Dive
New York, USA, July 11, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global medical tourism market is anticipated to generate a revenue of $149.34 billion and grow...
Image
First Ascent Biomedical Announces Innovation Collaborative With Lucem Health™ to Help Bring AI/ML to the Front Lines of Healthcare
June 10, 2022 07:00 ET | First Ascent Biomedical
MIAMI, June 10, 2022 (GLOBE NEWSWIRE) -- First Ascent Biomedical today announces it has partnered with Lucem Health™ as a founding member of the Lucem Health Innovation Collaborative, a partner...
TIP_link_300x300.jpg
Lymphedema Treatment Market Size Worth $11.58 billion by 2028 to Rise at a Stellar CAGR of 5.1% by 2028 | Exclusive Report By The Insight Partners
June 08, 2022 07:55 ET | The Insight Partners
New York, June 08, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on“Lymphedema Treatment Market Size and Forecast to 2028 – COVID-19 Impact and Global Analysis – by...
MetasTx-Logo_HoRes.jpg
MetasTx LLC Raises Funds, Engages Manufacturing Partner, And Advances Phase One Development
June 07, 2022 07:22 ET | MetasTx LLC
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) -- MetasTx LLC is driven to create novel therapeutics to treat and prevent metastasis of cancers. Harvey Homan, CEO and Co-Founder has...
anpac_logo_full color_stacked.png
AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
May 31, 2022 17:00 ET | AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, May 31, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...